STEPWISE treatment of uncontrolled HyperTensioN in primary care: a cluster randomised trial. - STEPWISE HT

Julius Centrum0 个研究点目标入组 240 人开始时间: 待定最近更新: 2024年4月23日

试验速览

暂无简介。

•Patients aged > 18 years and < 80 years with an office blood pressure > 140/90
•mmHg, on at least two blood pressure measurements per visit and on at least two
•occasions in the last year despite prescription of three or more blood pressure
•lowering drugs of different classes at adequate dosage, with for each
•antihypertensive drug at least 1 prescription of 3 months. During the inclusion
•consultation, the office blood pressure should be > 140/90 mmHg (measured
•according to the guideline on *standardized office blood pressure measurement
•based on the NHG CVRM guideline).

•- A short life expectancy (< 6 months) as judged by the GP.
•- Inability to understand or conform to the stepwise protocol.
•- Unwillingness to provide a written informed consent.
•- In case of suspicion of a hypertensive crisis (systolic blood pressure * 200
•mmHg and/or diastolic blood pressure * 120 mmHg) the patient is referred for
•further evaluation. If a hypertensive crisis is excluded, the patient can be
•included in the study.
•- Atrial fibrillation (because of difficulties to interpret 24 hour BP
•measurements)
•- Pregnancy or breast feeding.
•- Severe co-morbidity, which seriously interferes with diagnostic procedures or
•possible treatment.

发起方

Julius Centrum